Customization: | Available |
---|---|
Function: | Lowering Blood Pressure |
Certification: | GMP, ISO, HACCP, QS, KOSHER, NOP |
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product name
|
Nicotinamide Mononucleotide Reduced Nicotinamide Mononucleotide Nmnh Powder |
Latin Name
|
NMNH |
Color
|
WHRITE Powder
|
Specification
|
99% |
Formula
|
/ |
Solubility
|
Water Soluble 100% Instant
|
Particle Size
|
100% pass 80 mesh
|
NMNH is "reduced β-nicotinamide mononucleotide", which is the reduced form of NMN. The molecular formula of NMNH is C11H17N2O8P, molecular weight: 336.23g/mol, CAS No.: 108347-85-9, and it is an amorphous yellow powder. The latest research literature shows that NMNH increases NAD+ levels faster and at a higher concentration, which is an average of 5 times that of NMN. NMNH has been industrialized with a purity of ≥99% and is available in two forms: free acid and sodium salt.
Introduction:
1. NAD+ replenishment: NMNH can boost NAD+ levels, which decline with age. NAD+ is crucial for various cellular functions, including DNA repair and energy production.
2. Energy production: NAD+ is essential for the production of ATP, the cell's energy currency. NMNH supplementation may improve energy levels and metabolism.
3. Cognitive function: NMNH may support cognitive function by protecting neurons and promoting synaptic plasticity.
Neurodegenerative diseases: Preliminary research indicates that NMNH could have potential benefits for neurodegenerative diseases like Alzheimer's and Parkinson's.
Test Items | Test Standard |
Appearance | YELLOW powder |
Identification | IR |
Water | ≤1.0% |
Ash | ≤5.0% |
Particle size | 98% pass through 80 mesh |
Lead(Pb) | ≤0.5ppm |
As | ≤0.5ppm |
Hg | ≤0.1ppm |
Cd | ≤0.3ppm |
Total Plate Count | ≤1000cfu/g |
Yeast&Molds | ≤100cfu/g |
E.Coli. | Negative/1.0g |
Salmonella | Negative/1.0g |
Staphylococcus aureus | Negative/1.0g |
Assay (w/w; by HPLC) | ≥99.0% |
Assay (area%; by HPLC) | ≥99.0% |